Clinical Trial Detail

NCT ID NCT02285439
Title Phase I/II Study of MEK162 for Children With Ras/Raf Pathway Activated Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Children's Hospital Los Angeles , Dana-Farber Cancer Institute
Indications

Advanced Solid Tumor

Therapies

Binimetinib

Age Groups: adult child

Additional content available in CKB BOOST